| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8707474 | Oral Oncology | 2017 | 7 Pages |
Abstract
Docetaxel had a superior disease control rate at 6 weeks compared to cabazitaxel.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Amit Joshi, Vijay Patil, Vanita Noronha, Sachin Dhumal, Nikhil Pande, Arun Chandrasekharan, Siddharth Turkar, Hollis DSouza, Sameer Shrirangwar, Abhishek Mahajan, Supreeta Arya, Shashikant Juvekar, Atanu BhattaCharjee, Kumar Prabhash,